Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
3 participants
OBSERVATIONAL
2023-03-15
2023-07-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Synthetic Cartilage Implant Versus Interposition Arthroplasty in Hallux Rigidus Treatment: A Randomized Clinical Trial
NCT05518721
Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)
NCT05587569
Correction of Hallux Valgus with the Nexis® PECA Bunion Implantable Osteosynthesis Medical Device
NCT05361317
Minimally Invasive Versus Open Scarf Osteotomy for Hallux Valgus Correction: a Randomized Controlled Trial
NCT03575338
Short Term Follow-up of Patient Implanted With the Metatarso-Phalangeal Prosthesis METIS®
NCT01284985
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will be divided into two groups:
* patient undergoing arthrodesis of the hallux with a large diameter screw (group A)
* patient undergoing arthrodesis of the hallux by plate (group B)
This is a prospective, cross-sectional, open, comparative, non-randomized, non-interventional, monocentric study on two methods of synthesis (large-diameter plate or screw) of hallux metatarsophalangeal arthrodesis. Patients will be managed in accordance with current practice, the choice of surgical strategy (percutaneous / open) being left to the discretion of the investigators.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Metatarsophalangeal arthrodesis of the hallux with large diameter screws
Patient who can benefit from first-line arthrodesis using large-diameter screws
Arthrodesis of the metatarsophalangeal joint
Isolated surgery of the first ray of hallux valgus, hallux varus or hallux rigidus by percutaneous or conventional approach
Metatarsophalangeal arthrodesis of the hallux by plate
Patient who can benefit from a first intention arthrodesis by dorsal plate
Arthrodesis of the metatarsophalangeal joint
Isolated surgery of the first ray of hallux valgus, hallux varus or hallux rigidus by percutaneous or conventional approach
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Arthrodesis of the metatarsophalangeal joint
Isolated surgery of the first ray of hallux valgus, hallux varus or hallux rigidus by percutaneous or conventional approach
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient who can benefit from first-line arthrodesis using a dorsal plate or large-diameter screw;
* Patient able to understand information related to the study and complete quality of life questionnaires;
* Patient accepting study follow-up visits;
* Patient having been informed and agreeing to participate in the study.
Exclusion Criteria
* Patient undergoing lateral ray surgery;
* Patient undergoing revision arthrodesis;
* Patient with a loss of bone substance requiring a graft;
* Patient suffering from chronic inflammatory disease;
* Patient treated with long-term immunosuppressive or corticosteroid treatments;
* Patient under guardianship or curatorship, or under a regime of deprivation of liberty.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Euraxi Pharma
INDUSTRY
GCS Ramsay Santé pour l'Enseignement et la Recherche
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique Blomet
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A02518-35
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.